Transport
Gaffney Hma LLC
Gaffney Hma LLC was paid $1.23M by Medicaid between Jan 2018 and Dec 2018, across 126 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 13% of everything it billed.
33Billing provider infoGAFFNEY HMA LLC
GAFFNEY, SC 29340
GAFFNEY, SC 29340
33aNPI1508800186assigned 06/15/2006
33bProvider typeAmbulance
28Total paid$1.23M
24GClaims74,721
24DCodes billed126
24AFirst – last monthJan 2018 – Dec 2018
Compared with peers
Next to other Ambulance providers in South Carolina
Rank by total paid#16 of 51
Median peer was paid$630K
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 74,721 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 13% | 4,532 | 3,728 | $160K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10% | 1,042 | 963 | $126K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 7.5% | 821 | 748 | $92K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.9% | 5,696 | 5,021 | $85K |
| 87430 | 5.3% | 873 | 816 | $66K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.0% | 1,028 | 904 | $61K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.7% | 1,477 | 1,356 | $57K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3.6% | 386 | 355 | $44K |
| 84703 | 3.5% | 1,627 | 1,445 | $43K | |
| 84484 | 3.5% | 1,468 | 981 | $43K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3.1% | 730 | 663 | $38K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.9% | 1,039 | 933 | $35K |
114 more codes
| 71046 | Radiologic examination, chest; 2 views | 2.5% | 1,195 | $31K |
| 81001 | 1.9% | 3,428 | $24K | |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 6,274 | $24K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.8% | 176 | $22K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 272 | $21K |
| 99285 | Emergency room visit (most serious) | 1.7% | 1,424 | $21K |
| 86756 | 1.6% | 399 | $20K | |
| 86900 | 1.6% | 108 | $20K | |
| 83880 | 1.3% | 628 | $16K | |
| 87070 | 1.2% | 1,033 | $14K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 677 | $14K |
| 99284 | Emergency room visit (serious) | 1.0% | 3,637 | $12K |
| 87040 | <1% | 479 | $12K | |
| 74018 | <1% | 266 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 657 | $9K |
| 72100 | <1% | 307 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 245 | $8K |
| 84702 | <1% | 336 | $7K | |
| 73630 | <1% | 191 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,265 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,340 | $6K |
| 73130 | <1% | 154 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 539 | $4K |
| 73562 | <1% | 118 | $4K | |
| 87077 | <1% | 513 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 424 | $4K |
| 93971 | <1% | 30 | $4K | |
| 83655 | <1% | 175 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 28 | $4K |
| 73610 | <1% | 173 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 43 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 772 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 167 | $2K |
| 85610 | <1% | 425 | $2K | |
| 76801 | <1% | 163 | $2K | |
| 72050 | <1% | 55 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 42 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,688 | $1K |
| 73502 | <1% | 27 | $1K | |
| 85379 | <1% | 197 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 386 | $1K |
| 73030 | <1% | 83 | $1K | |
| 72070 | <1% | 12 | $1K | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | <1% | 147 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 569 | $960.82 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 27 | $781.39 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 96 | $780.72 |
| 74019 | <1% | 142 | $758.02 | |
| 73080 | <1% | 14 | $751.14 | |
| 76830 | Ultrasound, transvaginal | <1% | 174 | $747.10 |
| 77066 | Tomosynthesis, mammo | <1% | 16 | $721.43 |
| 80320 | <1% | 120 | $714.12 | |
| 73110 | <1% | 29 | $710.62 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 423 | $709.14 |
| G0378 | Hospital observation service, per hour | <1% | 320 | $646.76 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 666 | $492.31 |
| 87210 | <1% | 245 | $483.28 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 546 | $479.85 |
| 83605 | <1% | 298 | $410.76 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 188 | $391.91 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 238 | $344.44 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,273 | $335.08 |
| 94760 | <1% | 210 | $303.82 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 53 | $256.86 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 244 | $240.92 |
| 76642 | <1% | 15 | $169.02 | |
| 80061 | Lipid panel | <1% | 224 | $81.88 |
| 83690 | <1% | 1,023 | $56.49 | |
| 74022 | <1% | 149 | $44.40 | |
| 82962 | <1% | 72 | $35.33 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 558 | $34.46 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 666 | $3.12 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 866 | $0.41 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 115 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 285 | $0.00 |
| 84439 | 0% | 219 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 98 | $0.00 |
| 85007 | 0% | 426 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 857 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 258 | $0.00 |
| 87186 | 0% | 421 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 259 | $0.00 |
| 82010 | 0% | 47 | $0.00 | |
| 93017 | 0% | 41 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 265 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 19 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 83 | $0.00 |
| 90714 | 0% | 28 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 12 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 13 | $0.00 |
| 82550 | 0% | 796 | $0.00 | |
| 85730 | 0% | 355 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 602 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 392 | $0.00 |
| 82150 | 0% | 404 | $0.00 | |
| 82553 | 0% | 926 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 310 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 556 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 227 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 166 | $0.00 |
| 87205 | 0% | 204 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 139 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 79 | $0.00 |
| 88304 | 0% | 94 | $0.00 | |
| 84436 | 0% | 159 | $0.00 | |
| 83735 | 0% | 594 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 146 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 103 | $0.00 |
| 85027 | 0% | 44 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 35 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 12 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 16 | $0.00 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 0% | 20 | $0.00 |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.